Azierta fully integrated into QbD Group

What does this change mean?

This integration is more than a name change, it’s a transformation that strengthens our combined expertise, delivering greater value to our clients and employees while enhancing our ability to support life sciences companies worldwide.

The integration of Azierta into QbD Group marks a significant opportunity for our employees. This transition fosters a more dynamic, innovative, and inclusive workplace where everyone can grow, collaborate, and thrive.

– Pilar Rotaeche, HR Director

A unified vision: insights on the integration

Client-centric growth

This integration strengthens Azierta’s ability to drive innovation and provide comprehensive solutions that address the evolving needs of the life sciences industry. Our expanded service portfolio ensures that we remain a trusted partner in regulatory compliance, product development, and market access.

Unlocking new opportunities

From a business perspective, this integration strengthens client relationships and unlocks new cross-selling opportunities. Azierta’s expertise in regulatory affairs and pharmacovigilance now complements QbD Group’s strengths in medical devices, IVD, and clinical services, offering a seamless, integrated approach.

This integration positions us as a one-stop shop for life sciences consultancy. We’re not just offering individual services - we’re providing comprehensive solutions that support the entire product lifecycle.

- Antonio Borregón, Business Developer

Looking ahead: a stronger future as QbD Group

With Azierta now fully part of QbD Group, we are reinforcing our commitment to delivering unparalleled value to clients, fostering a strong workplace culture, and driving innovation across the life sciences sector.